<code id='D2EFD29B7C'></code><style id='D2EFD29B7C'></style>
    • <acronym id='D2EFD29B7C'></acronym>
      <center id='D2EFD29B7C'><center id='D2EFD29B7C'><tfoot id='D2EFD29B7C'></tfoot></center><abbr id='D2EFD29B7C'><dir id='D2EFD29B7C'><tfoot id='D2EFD29B7C'></tfoot><noframes id='D2EFD29B7C'>

    • <optgroup id='D2EFD29B7C'><strike id='D2EFD29B7C'><sup id='D2EFD29B7C'></sup></strike><code id='D2EFD29B7C'></code></optgroup>
        1. <b id='D2EFD29B7C'><label id='D2EFD29B7C'><select id='D2EFD29B7C'><dt id='D2EFD29B7C'><span id='D2EFD29B7C'></span></dt></select></label></b><u id='D2EFD29B7C'></u>
          <i id='D2EFD29B7C'><strike id='D2EFD29B7C'><tt id='D2EFD29B7C'><pre id='D2EFD29B7C'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:4424
          Priscilla Chan, left, with Shana Kelley and Gov. J.B. Pritzker of Illinois at the new CZ Biohub Chicago. Courtesy Dale Ramos/Chan Zuckerberg Initiative

          CHICAGO — At what point does inflammation, a key component of the body’s immune defense system, swerve out of control and start to drive disease?

          That’s the key question that a new research center, the Chan Zuckerberg Biohub Chicago, has been created to try to answer.

          advertisement

          The Chicago hub is the second one started by the Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife, Priscilla Chan. The first hub, based in the Bay Area, has been investigating cell biology and infectious diseases, while this new one is homing in on inflammatory processes in tissues across the body.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          Readout Newsletter: Bayer study halts, Carmot to IPO, and more
          Readout Newsletter: Bayer study halts, Carmot to IPO, and more

          KenaBetancur/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbi

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          A daunting task: navigating dual Medicare, Medicaid eligibility

          AdobeThreemonthsago,myauntMargarethadastroke.Daysbefore,shewasrepaintingherbathroomanddrivingherself